Cargando…

2101. CMV Infections in Multiple Myeloma Patients

BACKGROUND: Substantial progress in the treatment of multiple myeloma (MM) has led to improved patient outcomes and prolonged survival of patients. These therapeutic advances have resulted in increased cumulative immunosuppression leading to increased susceptibility to opportunistic infections inclu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ilyas, Sahrish, Jacobs, Samantha E, Rana, Meenakshi, Baneman, Emily
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752721/ http://dx.doi.org/10.1093/ofid/ofac492.1723

Ejemplares similares

1741. Invasive Fungal Infections in Patients with Multiple Myeloma in the Era of Novel Therapies
por: Baneman, Emily, et al.
Publicado: (2019)

2101. Impact of “Code Sepsis” on Antimicrobial Utilization at an Academic Medical Center
por: Kang, Minji, et al.
Publicado: (2019)

583. Successful prevention of Strongyloides reactivation in liver transplant recipients with individualized screening and treatment: 10 year experience at a large transplant center in New York City
por: Rahman, Farah, et al.
Publicado: (2020)

2101. Catheter-related Infections Complicating Central Venous Catheter Access Device Insertion: A Retrospective Audit and Comparison of Two Cohorts
por: Hoey, Anne, et al.
Publicado: (2018)

Prognostic value of low muscle mass at the 12(th) thoracic vertebral level in multiple myeloma treated with transplantation: CAREMM-2101 study
por: Park, Sung-Soo, et al.
Publicado: (2023)

2121. The Impact of Donor CMV Serostatus on Outcomes of CMV Infections in the Era of Letermovir
por: Aramburo, Oscar Morado, et al.
Publicado: (2022)

143. Correlation Between Identification of Gram-positive Resistance Genes and Antimicrobial Susceptibility Profiles in Gram Positive Bacteria
por: Ilyas, Sahrish, et al.
Publicado: (2023)

940. The use of a commercially available CMV T Cell Immunity Panel to Assess the Risk of CMV Infections in Hematopoietic Cell Transplant Recipients with Low Level CMV Viremia
por: Khawaja, Fareed, et al.
Publicado: (2021)

256. Characterization of the Placental Proteome during Congenital CMV Infection
por: Farnan, Sheila K, et al.
Publicado: (2023)

Respiratory Viral Infections in Multiple Myeloma Patients
por: Burgess, Mary J, et al.
Publicado: (2017)

Detection of Cytomegalovirus (CMV) in Saliva of Congenitally Infected Neonates
por: Wissel, Mark, et al.
Publicado: (2017)

1747. Impact of Inappropriately Low Cytomegalovirus (CMV) Prophylaxis Dosing on CMV Outcomes Among Lung Transplant (LT) Recipients
por: Watts, Corey, et al.
Publicado: (2019)

1198. Measurement of Pre-transplant Anti-cytomegalovirus (CMV) Immunoglobulin G Titer to Predict Risk of CMV Infection in CMV-seropositive Kidney Transplant Recipients
por: Kirisri, Similan, et al.
Publicado: (2020)

A Mortality Analysis of the Cytomegalovirus (CMV) Infection Letermovir Prophylaxis Trial in CMV-Seropositive Recipients of Allogeneic Hematopoietic Cell Transplantation (HCT)
por: Maertens, Johan, et al.
Publicado: (2017)

Ganciclovir-resistant CMV (GCV-R CMV) Infection Leads to Poor Clinical Outcomes and Economic Burden of Ganciclovir-resistant Cytomegalovirus Infection in Lung Transplant Recipients
por: Patel, Twisha, et al.
Publicado: (2017)

2101: Addressing African American glaucoma through genetics and electronic health records
por: Cooke Bailey, Jessica, et al.
Publicado: (2018)

Blood Viral Load (VL) Not Clinically Meaningful in Symptomatic Congenital Cytomegalovirus (cCMV) Infection
por: Marsico, Concetta, et al.
Publicado: (2017)

1590. A Hybrid CMV Prevention Strategy Is Effective in Preventing CMV Disease Outcomes in Pediatric Solid Organ Transplant Patients
por: Ore, Lucia Dalle, et al.
Publicado: (2018)

“Targeted” Screening for Cytomegalovirus (CMV)-Related Hearing Loss: It’s Time for Universal CMV Screening in the NICU!
por: Medoro, Alexandra, et al.
Publicado: (2017)

1566. Is Primary CMV Infection Post-transplant Influenced by Circadian Rhythms?
por: Rafferty, Hannah, et al.
Publicado: (2018)

417. Cytomegalovirus (CMV) and Sexually Transmitted infections (STIs) During Pregnancy
por: Geetha Pinninti, Swetha, et al.
Publicado: (2019)

Multiple Myeloma
Publicado: (2019)

Impact of CMV Blips in Transplant Recipients
por: Lodding, Isabelle Paula, et al.
Publicado: (2017)

2591. The Role of Neutralizing Antibodies (nAb) Against Cytomegalovirus (CMV) Epithelial Cell-entry in Patients with Self-limited (SL) CMV infection after Hematopoietic Cell Transplantation (HCT)
por: Zamora, Danniel, et al.
Publicado: (2019)

604 Risk Factors for Cytomegalovirus (CMV) Reactivation in CMV-seropositive Liver Transplant Patients
por: Bruminhent, Jackrapong, et al.
Publicado: (2014)

998 Detection of Cytomegalovirus (CMV) in Cerebrospinal Fluid of Infants with Congenital CMV Infection: Is It Worth Doing the Lumbar Puncture?
por: Ouellette, Christopher, et al.
Publicado: (2014)

1744. CMV Infection and Management Among Pediatric Solid-Organ Transplant Recipients
por: Sharova, Anna, et al.
Publicado: (2019)

Programmatic Congenital CMV Universal Screening Program
por: Carrillo-Marquez, Maria, et al.
Publicado: (2017)

1561. Outcomes of Resistant or Refractory CMV Infection in Recipients of Allogeneic Hematopoietic Cell Transplant
por: Artau, Annette, et al.
Publicado: (2018)

968. Universal Newborn Testing for Congenital Cytomegalovirus (cCMV) Infection Comes of Age: Clinical Sensitivity of Screening Tests and Infant Outcomes in a cCMV Screening Study in Minnesota
por: Schleiss, Mark R, et al.
Publicado: (2023)

768. Digital Patient Education: A Tool to Improve Awareness of CMV
por: Larkin, Amy, et al.
Publicado: (2023)

2696. Impact of an Ultrasensitive Cytomegalovirus (CMV) Quantitative Nucleic Acid Test (qNAT) on CMV Detection and Therapy in Renal Transplant Recipients
por: Beechar, Vivek, et al.
Publicado: (2023)

Hypophosphatemia in Patients With Multiple Myeloma
por: Cancarevic, Ivan, et al.
Publicado: (2023)

91. Differential Impact of Cytomegalovirus (CMV) Donor (D) Serostatus on Rates and Kinetics of CMV Viremia among CMV Seropositive Recipients (R+) of Ex vivo T-cell Depleted (TCD) and Unmodified (CONV) Hematopoietic Cell Transplants (HCT)
por: Stern, Anat, et al.
Publicado: (2019)

WS21.01 AQP5 and CFTR, two genes associated with pseudo-aquagenic palmoplantar keratoderma?
por: Girodon, E., et al.
Publicado: (2022)

1897. Letermovir Salvage for Complicated Cases of Resistant CMV
por: Turner, Nicholas, et al.
Publicado: (2018)

491. Characterizing the Association of Pre-Existing Cytomegalovirus (CMV)-specific Humoral Immunity with CMV Reactivation Risk after Hematopoietic Cell Transplantation (HCT)
por: Zamora, Danniel, et al.
Publicado: (2022)

Head Ultrasound or MRI? The Role of Neuroimaging in the Assessment of Symptomatic and Asymptomatic Infants with Congenital CMV Infection
por: Smiljkovic, Mina, et al.
Publicado: (2017)

Incidence and Outcomes of Cytomegalovirus (CMV) Infection among Hematopoietic Stem Cell Transplant (HSCT) Recipients
por: Furuno, Jon P, et al.
Publicado: (2017)

P01 Antibiotic efficacy treatment of community-acquired pneumonia among CMV-infected individuals
por: Chichirelo-Konstantynovych, Kiarina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cqujj922rsolv3cd2s032vifvi